Author:
Cybulski Cezary,Wokołorczyk Dominika,Kładny Józef,Kurzwaski Grzegorz,Suchy Joanna,Grabowska Ewa,Gronwald Jacek,Huzarski Tomasz,Byrski Tomasz,Górski Bohdan,Dȩbniak Tadeusz,Narod Steven A,Lubiński Jan
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics
Reference34 articles.
1. Matsuoka S, Rotman G, Ogawa A, Shiloh Y, Tamai K, Elledge SJ : Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc Natl Acad Sci USA 2000; 97: 10389–10394.
2. Chaturvedi P, Eng WK, Zhu Y et al: Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 1999; 18: 4047–4054.
3. Bell DW, Varley JM, Szydlo TE et al: Heterozygous germ line hCHK2 mutations in Li–Fraumeni syndrome. Science 1999; 286: 2528–2531.
4. Vahteristo P, Tamminen A, Karvinen P et al: p53, CHK2, and CHK1 genes in Finnish families with Li–Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition. Cancer Res 2001; 61: 5718–5722.
5. CHEK2 Breast Cancer Consortium: Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 2002; 31: 55–59.
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献